. 2023 Jul 20;62:102100. doi: 10.1016/j.eclinm.2023.102100

Table 4.

The results of network meta-analysis for SUCRA.

Treatment	LCQ	24 h cough frequency	Cough severity VAS
Placebo	0.327	0.472	0.425
Gefapixant	0.711	0.983	0.786
Eliapixant	0.555	0.392	0.667
XEN-D0501	0.39	0.192	ND^a
GSK2798745	0.304	ND^a	0.284
SB-705498	ND^a	0.328	0.331
Lesogaberan	0.529	0.632	0.601
Azithromycin	0.671	ND^a	ND^a
PA-101	0.514	ND^a	0.397

Abbreviations: SUCRA, surface under the cumulative ranking curve; LCQ, leicester cough questionnaire.

ND, this medication was not included in the network meta-analysis.